MoneyWorks4Me

Glaxosmithkline Pharmaceuticals informs about analyst meet

18 Sep 2020 Evaluate
Pursuant to Regulation 30(6) of the Schedule Ill, of the Listing Obligations and Disclosure requirements (LODR), Regulations, 2015, Glaxosmithkline Pharmaceuticals has informed about the details of Analyst or Institutional Meetings with the Company scheduled on 28th September 2020.
The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..